Carrie W. Rinker-Schaeffer to Male
This is a "connection" page, showing publications Carrie W. Rinker-Schaeffer has written about Male.
Connection Strength
0.251
-
MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer. 2012 Feb 01; 130(3):509-20.
Score: 0.019
-
Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Mol Cancer Res. 2008 Mar; 6(3):501-8.
Score: 0.016
-
Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. J Pathol. 2007 Aug; 212(4):386-94.
Score: 0.015
-
Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 2005 Dec 01; 65(23):10984-91.
Score: 0.013
-
Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12. Int J Cancer. 2004 Jan 01; 108(1):15-22.
Score: 0.012
-
The basic biology of metastasis. Cancer Treat Res. 2004; 118:1-21.
Score: 0.012
-
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol. 2003 Mar; 169(3):1122-33.
Score: 0.011
-
Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 2001 Apr 01; 61(7):2833-7.
Score: 0.010
-
Metastasis suppression in prostate cancer. Cancer Metastasis Rev. 2001; 20(3-4):279-86.
Score: 0.009
-
Defining the biologic role of genes that regulate prostate cancer metastasis. Curr Opin Urol. 2000 Sep; 10(5):397-401.
Score: 0.009
-
The Dunning model. Prostate. 2000 Jun 01; 43(4):295-302.
Score: 0.009
-
Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 1999 Nov 01; 59(21):5483-7.
Score: 0.009
-
Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res. 1998 Nov 01; 58(21):4963-9.
Score: 0.008
-
Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential. Clin Cancer Res. 1998 Oct; 4(10):2391-8.
Score: 0.008
-
Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res. 1998 Aug 15; 58(16):3561-5.
Score: 0.008
-
Prostate cancer metastasis-suppressor genes: a current perspective. In Vivo. 1998 Jan-Feb; 12(1):49-58.
Score: 0.008
-
Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate. 1997 Dec 01; 33(4):271-80.
Score: 0.008
-
The role of motility proteins and metastasis-suppressor genes in prostate cancer progression. Stem Cells. 1996 Sep; 14(5):508-16.
Score: 0.007
-
Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase. Prostate. 1996 Jul; 29(1):60-4.
Score: 0.007
-
Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics. 1995 Nov 01; 30(1):105-8.
Score: 0.007
-
Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 1994 Dec 01; 54(23):6249-56.
Score: 0.006
-
Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate. 1994 Nov; 25(5):249-65.
Score: 0.006
-
Molecular and cellular markers for metastatic prostate cancer. Cancer Metastasis Rev. 1993 Mar; 12(1):3-10.
Score: 0.005
-
FYN is overexpressed in human prostate cancer. BJU Int. 2009 Jan; 103(2):171-7.
Score: 0.004
-
Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells. J Urol. 2004 Dec; 172(6 Pt 2):2539-44.
Score: 0.003
-
Highlights of the Society of Urologic Oncology meeting, June 2, 2001. J Urol. 2002 Aug; 168(2):653-9.
Score: 0.003
-
Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8.
Score: 0.003
-
Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
Score: 0.002
-
Mapping of metastasis suppressor genes for prostate cancer by microcell-mediated chromosome transfer. Asian J Androl. 2000 Sep; 2(3):167-71.
Score: 0.002
-
Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9.
Score: 0.002
-
Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res. 1998 Oct 15; 58(20):4572-6.
Score: 0.002
-
Workgroup I: rodent models of prostate cancer. Prostate. 1998 Jun 15; 36(1):49-55.
Score: 0.002
-
Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol. 1998; 41(6):505-12.
Score: 0.002
-
Prostate cancer--biology of metastasis and its clinical implications. World J Urol. 1996; 14(3):182-9.
Score: 0.002
-
Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer. 1995 Oct; 14(2):112-9.
Score: 0.002
-
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995 May 12; 268(5212):884-6.
Score: 0.002